i-123-5-ia85380
Small moleculeexperimentalImaging agent
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2009 (NCT00996034)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 123-iodine
Oral
No
Parenteral
No
Topical
No
Also known as
- [123] 5-i-a-85380
- 123i 5-ia-85380
- 123i 5-ia-85380
- i-123-5-ia85380
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00996034 | Phase 2 | Sep 1, 2009 | Nabi Biopharmaceuticals, National Institute on Drug Abuse (NIDA), Yale University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Nabi Biopharmaceuticals | For profit | 1 | 0 | 1 | 2009 |
| National Institute on Drug Abuse (NIDA) | Government | 1 | 0 | 1 | 2009 |
| Yale University | Academic/Hospital | 1 | 1 | 1 | 2009 |
3 organizations
Page 1 / 1